The Weizmann Institute of Science in Rehovot, Israel, has devised a
noninvasive technique for diagnosing whether a tumour is benign or malignant. A
contrast-enhancing dye is injected into the patient’s bloodstream and magnetic
resonance imaging is used to watch it pass through the tumour. The spaces
between cells and the presence or absence of blood vessels determine the rate at
which the dye passes through. In benign tumours the dye accumulates and washes
out slowly, but in malignant cancers it passes straight through.
More from New Å®ÉúСÊÓƵ
Explore the latest news, articles and features
Humans
Mystery of the ancient giant stone jars of Laos may have been solved
News
Mind
Floatation tanks deployed to combat PTSD after devastating wildfires
News
Mind
What is love? Even a meeting on the subject can't find the answer
News
Mind
How I used psychology to come back from the worst year of my life
Features
Popular articles
Trending New Å®ÉúСÊÓƵ articles
1
The ‘doomsday’ glacier’s giant ice shelf is about to break away
2
How I used psychology to come back from the worst year of my life
3
Why autism pioneer Uta Frith wants to dismantle the spectrum
4
PCOS has been officially renamed PMOS, and it’s a momentous move
5
The 3 things you need to know about protein, according to an expert
6
The hidden pockets of the universe where the future can cause the past
7
Mystery of the ancient giant stone jars of Laos may have been solved
8
Melting of Greenland ice sheet could release methane 'fire ice'
9
Asteroid set to fly very close to Earth
10
What if the idea of the autism spectrum is completely wrong?
